Dr. Morton MD Coleman, doctor
Claim this profileClinical Research Alliance
Studies Lymphoma
Studies Non-Hodgkin's Lymphoma
12 reported clinical trials
26 drugs studied
Area of expertise
1Lymphoma
Stage I
Stage II
Stage IV
2Non-Hodgkin's Lymphoma
Affiliated Hospitals
Clinical Trials Morton MD Coleman, doctor is currently running
Ivaltinostat + Capecitabine
for Pancreatic Cancer
This trial tests ivaltinostat with capecitabine in patients with advanced pancreatic cancer who have not worsened after initial treatment. The goal is to find a safe and effective dose and to see if this combination can better control the cancer. Capecitabine is a medication that is converted into another drug in the body, showing better selectivity and tolerability in tumor tissues.
Recruiting3 awards Phase 1 & 211 criteria
GFH009
for Blood Cancer
SLS009 (formerly GFH009) is a potent and highly selective CDK9 inhibitor. In this study the safety, tolerability, and antitumor activity of single agent SLS009 are assessed in two dose escalation groups (Group 1 in patients with relapsed/refractory AML, Group 2 in patients with relapse/refractory lymphoma/CLL/SLL). The safety, tolerability, and antitumor activity of SLS009 in combination with venetoclax and azacitidine in patient with relapsed/refractory AML who have relapsed on or are refractory to venetoclax-based regimens are being assessed in five cohorts of the expansion Group 3.
Recruiting1 award Phase 1 & 27 criteria
More about Morton MD Coleman, doctor
Clinical Trial Related9 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Morton MD Coleman, doctor has experience with
- Rituximab
- Bendamustine
- HMPL-523
- GFH009
- Brentuximab Vedotin
- Doxorubicin
Breakdown of trials Morton MD Coleman, doctor has run
Lymphoma
Non-Hodgkin's Lymphoma
Chronic B-Cell Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Morton MD Coleman, doctor specialize in?
Morton MD Coleman, doctor focuses on Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved Stage I patients, or patients who are Stage II.
Is Morton MD Coleman, doctor currently recruiting for clinical trials?
Yes, Morton MD Coleman, doctor is currently recruiting for 2 clinical trials in New Hyde Park New York. If you're interested in participating, you should apply.
Are there any treatments that Morton MD Coleman, doctor has studied deeply?
Yes, Morton MD Coleman, doctor has studied treatments such as Rituximab, Bendamustine, HMPL-523.
What is the best way to schedule an appointment with Morton MD Coleman, doctor?
Apply for one of the trials that Morton MD Coleman, doctor is conducting.
What is the office address of Morton MD Coleman, doctor?
The office of Morton MD Coleman, doctor is located at: Clinical Research Alliance, New Hyde Park, New York 11042 United States. This is the address for their practice at the Clinical Research Alliance.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.